Pages that link to "Q48208784"
Jump to navigation
Jump to search
The following pages link to Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression (Q48208784):
Displaying 50 items.
- Neuroplasticity and the next wave of antidepressant strategies (Q21129480) (← links)
- Depression research: where are we now? (Q21198902) (← links)
- Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry (Q21203922) (← links)
- Aging, stress and the hippocampus (Q23911375) (← links)
- Depression, cytokines, and glial function (Q24170129) (← links)
- Fibroblast growth factor receptor 1- 5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity (Q24294811) (← links)
- Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients (Q24541308) (← links)
- The role of the hippocampus in the pathophysiology of major depression (Q24561923) (← links)
- A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide (Q24607978) (← links)
- Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disorders (Q24632757) (← links)
- Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders (Q24632936) (← links)
- Research advances in geriatric depression (Q24642269) (← links)
- Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA in major depression (Q24644660) (← links)
- The subgenual anterior cingulate cortex in mood disorders (Q24649017) (← links)
- The neurobiology of retinoic acid in affective disorders (Q24654189) (← links)
- Erythropoietin Pathway: A Potential Target for the Treatment of Depression (Q26750850) (← links)
- Dendritic Spines in Depression: What We Learned from Animal Models (Q26765612) (← links)
- A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue (Q26770756) (← links)
- Depression as a Glial-Based Synaptic Dysfunction (Q26772830) (← links)
- Glia in the cytokine-mediated onset of depression: fine tuning the immune response (Q26798929) (← links)
- Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue (Q26827833) (← links)
- Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity? (Q26829556) (← links)
- A putative functional role for oligodendrocytes in mood regulation (Q26995174) (← links)
- Biomarkers of epileptogenesis: psychiatric comorbidities (?) (Q27015612) (← links)
- Glial degeneration as a model of depression (Q27015761) (← links)
- GABA interneurons mediate the rapid antidepressant-like effects of scopolamine (Q27329758) (← links)
- Role of NG2 expressing cells in addiction: a new approach for an old problem (Q28082885) (← links)
- PET imaging of serotonin 1A receptor binding in depression (Q28138956) (← links)
- Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins (Q28189235) (← links)
- NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development (Q28205016) (← links)
- Neural and behavioral substrates of mood and mood regulation (Q28205276) (← links)
- Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine (Q28238686) (← links)
- Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity (Q28256557) (← links)
- Neurobiological and clinical effects of the antidepressant tianeptine (Q28260673) (← links)
- Glucose metabolic changes in the prefrontal cortex are associated with HPA axis response to a psychosocial stressor (Q28272491) (← links)
- Captodiamine, a putative antidepressant, enhances hypothalamic BDNF expression in vivo by synergistic 5-HT2c receptor antagonism and sigma-1 receptor agonism (Q28294674) (← links)
- Nine-Year Risk of Depression Diagnosis Increases With Increasing Self-Reported Concussions in Retired Professional Football Players (Q28315584) (← links)
- The GABAβ receptor as a target for antidepressant drug action (Q28476654) (← links)
- Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures (Q28579755) (← links)
- Decreased expression of synapse-related genes and loss of synapses in major depressive disorder (Q28580177) (← links)
- Antidepressants elevate GDNF expression and release from C₆ glioma cells in a β-arrestin1-dependent, CREB interactive pathway (Q28581188) (← links)
- Nitric oxide signaling in the development and evolution of language and cognitive circuits (Q28650527) (← links)
- The concept of allostasis in biology and biomedicine (Q29029448) (← links)
- mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists (Q29618120) (← links)
- Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus (Q29619400) (← links)
- Chronic stress and brain plasticity: Mechanisms underlying adaptive and maladaptive changes and implications for stress-related CNS disorders (Q30371216) (← links)
- Fear extinction as a model for synaptic plasticity in major depressive disorder (Q30421426) (← links)
- Advances in the treatment of anxiety: targeting glutamate (Q30457479) (← links)
- Imaging phenotypes of major depressive disorder: genetic correlates (Q30478592) (← links)
- Effects of mental illness and aging in two thalamic nuclei (Q30485576) (← links)